Formation of the black-hole binary M33 X-7 via mass-exchange in a tight massive system

M33 X-7 is among the most massive X-Ray binary stellar systems known, hosting a rapidly spinning 15.65 Msun black hole orbiting an underluminous 70 Msun Main Sequence companion in a slightly eccentric 3.45 day orbit. Although post-main-sequence mass transfer explains the masses and tight orbit, it leaves unexplained the observed X-Ray luminosity, star's underluminosity, black hole's spin, and eccentricity. A common envelope phase, or rotational mixing, could explain the orbit, but the former would lead to a merger and the latter to an overluminous companion. A merger would also ensue if mass transfer to the black hole were invoked for its spin-up. Here we report that, if M33 X-7 started as a primary of 85-99 Msun and a secondary of 28-32 Msun, in a 2.8-3.1 day orbit, its observed properties can be consistently explained. In this model, the Main Sequence primary transferred part of its envelope to the secondary and lost the rest in a wind; it ended its life as a ~16 Msun He star with a Fe-Ni core which collapsed to a black hole (with or without an accompanying supernova). The release of binding energy and, possibly, collapse asymmetries "kicked" the nascent black hole into an eccentric orbit. Wind accretion explains the X-Ray luminosity, while the black hole spin can be natal.Comment: Manuscript: 18 pages, 2 tables, 2 figure. Supplementary Information: 34 pages, 6 figures. Advance Online Publication (AOP) on http://www.nature.com/nature on October 20, 2010. To Appear in Nature on November 4, 201

Manipulation of ionized impurity scattering for achieving high thermoelectric performance in n-type Mg

Achieving higher carrier mobility plays a pivotal role for obtaining potentially high thermoelectric performance. In principle, the carrier mobility is governed by the band structure as well as by the carrier scattering mechanism. Here, we demonstrate that by manipulating the carrier scattering mechanism in n-type Mg[subscript 3]Sb[subscript 2 ]-based materials, a substantial improvement in carrier mobility, and hence the power factor, can be achieved. In this work, Fe, Co, Hf, and Ta are doped on the Mg site of Mg[subscript 3.2]Sb[subscript 1.5]Bi[subscript 0.49]Te [subscript 0.01], where the ionized impurity scattering crosses over to mixed ionized impurity and acoustic phonon scattering. A significant improvement in Hall mobility from ∼16 to ∼81 cm 2 ·V[superscript −1]·s[superscript − 1] is obtained, thus leading to a notably enhanced power factor of ∼13 μW·cm [superscript −1]·K [superscript −2] from ∼5 μW·cm[superscript −1]·K[superscript −2]. A simultaneous reduction in thermal conductivity is also achieved. Collectively, a figure of merit (ZT) of ∼1.7 is obtained at 773 K in Mg[subscript 3.1]Co[subscript 0.1]Sb[subscript 1.5]Bi[subscript 0.49]Te [subscript 0.01]. The concept of manipulating the carrier scattering mechanism to improve the mobility should also be applicable to other material systems. Keywords: thermoelectric; carrier scattering mechanism; ionized impurity scattering; n-type; Mg[subscript 3]Sb[subscript 2]; defect

Phase-dependent study of near-infrared disk emission lines in LB-1

The mass, origin and evolutionary stage of the binary system LB-1 has been the subject of intense debate, following the claim that it hosts an $\sim$70$M_{\odot}$ black hole, in stark contrast with the expectations for stellar remnants in the Milky Way. We conducted a high-resolution, phase-resolved spectroscopic study of the near-infrared Paschen lines in this system, using the 3.5-m telescope at Calar Alto Observatory. We find that Pa$\beta$ and Pa$\gamma$ (after proper subtraction of the stellar absorption component) are well fitted with a standard double-peaked model, typical of disk emission. We measured the velocity shifts of the red and blue peaks at 28 orbital phases: the line center has an orbital motion in perfect antiphase with the stellar motion, and the radial velocity amplitude ranges from 8 to 13 km/s for different choices of lines and profile modelling. We interpret this curve as proof that the disk is tracing the orbital motion of the primary, ruling out the circumbinary disk and the hierarchical triple scenarios. The phase-averaged peak-to-peak half-separation (proxy for the projected rotational velocity of the outer disk) is $\sim$70 km s$^{-1}$, larger than the stellar orbital velocity and also inconsistent with a circumbinary disk. From those results, we infer a primary mass 4--8 times higher than the secondary mass. Moreover, we show that the ratio of the blue and red peaks (V/R intensity ratio) has a sinusoidal behaviour in phase with the secondary star, which can be interpreted as the effect of external irradiation by the secondary star on the outer disk. Finally, we briefly discuss our findings in the context of alternative scenarios recently proposed for LB-1. Definitive tests between alternative solutions will require further astrometric data from $Gaia$.Comment: To be submitted to ApJ. Comments are welcom

Loss-of-Function Genomic Variants Highlight Potential Therapeutic Targets for Cardiovascular Disease

Pharmaceutical drugs targeting dyslipidemia and cardiovascular disease (CVD) may increase the risk of fatty liver disease and other metabolic disorders. To identify potential novel CVD drug targets without these adverse effects, we perform genome-wide analyses of participants in the HUNT Study in Norway (n = 69,479) to search for protein-altering variants with beneficial impact on quantitative blood traits related to cardiovascular disease, but without detrimental impact on liver function. We identify 76 (11 previously unreported) presumed causal protein-altering variants associated with one or more CVD- or liver-related blood traits. Nine of the variants are predicted to result in loss-of-function of the protein. This includes ZNF529:p.K405X, which is associated with decreased low-density-lipoprotein (LDL) cholesterol (P = 1.3 × 10−8) without being associated with liver enzymes or non-fasting blood glucose. Silencing of ZNF529 in human hepatoma cells results in upregulation of LDL receptor and increased LDL uptake in the cells. This suggests that inhibition of ZNF529 or its gene product should be prioritized as a novel candidate drug target for treating dyslipidemia and associated CVD